tiprankstipranks
Trending News
More News >
Urogen Pharma (URGN)
NASDAQ:URGN

Urogen Pharma (URGN) Revenue

Compare
652 Followers

Urogen Pharma Revenue

Urogen Pharma had a revenue of 27.48M in the quarter ending Sep 30, 2025, with Infinity%. This bring the company's revenue in the last twelve months to 72.30M, Decreased 3.25%. In the fiscal year ending Dec 31, 2024, Urogen Pharma had annual revenue of 90.40M with 9.29% growth.
Revenue (ttm)
72.30M
Revenue Growth
8.00%
P/S Ratio
12.30
Revenue/Employee
$386,316
Employees
234
Market Cap
$1.11B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
90.40M7.68M+109.29%
Dec 31, 2023
82.71M18.36M+128.52%
Dec 31, 2022
64.36M16.32M+133.96%
Dec 31, 2021
48.04M36.24M+407.17%
Dec 31, 2020
11.80M11.78M+65,553.64%
Dec 31, 2019
18.00K-1.11M+1.60%
Dec 31, 2018
1.13M-7.03M+13.83%
Dec 31, 2017
8.16M-9.37M+46.54%
Dec 31, 2016
17.53M